Haibo Wang

4.5k total citations · 1 hit paper
165 papers, 2.5k citations indexed

About

Haibo Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haibo Wang has authored 165 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 55 papers in Oncology and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haibo Wang's work include Natural Compounds in Disease Treatment (25 papers), Natural product bioactivities and synthesis (17 papers) and Cancer Cells and Metastasis (15 papers). Haibo Wang is often cited by papers focused on Natural Compounds in Disease Treatment (25 papers), Natural product bioactivities and synthesis (17 papers) and Cancer Cells and Metastasis (15 papers). Haibo Wang collaborates with scholars based in China, Japan and United States. Haibo Wang's co-authors include Yanqing Liu, Xiangping Liu, Yayun Qian, Zhi‐Dong Lv, Tengyang Ni, Weihong Cao, Xiaoyi Liu, Funian Li, Weijun Zhao and Shiyu Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Haibo Wang

159 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile

2023 82 citations Haibo Wang et al. profile →

Peers

Haibo Wang

ONCOL

PRM

SURGE

Na Han China

Shuai Zhang China

Min Xu China

Bei Zhang China

Yue Xi China

Bing Xu China

Jianwei Xu China

Ana Bela Sarmento‐Ribeiro Portugal

Faruk Taş Türkiye

Yoichi Matsuo Japan

Na Han China

Haibo Wang

1.2k ×1.0

652 ×1.0

ONCOL

444 ×0.9

425 ×1.1

PRM

288 ×1.1

SURGE

Citations per year, relative to Haibo Wang Haibo Wang (= 1×) peers Na Han

Countries citing papers authored by Haibo Wang

Since Specialization

Citations

This map shows the geographic impact of Haibo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Wang more than expected).

Fields of papers citing papers by Haibo Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Wang. The network helps show where Haibo Wang may publish in the future.

Co-authorship network of co-authors of Haibo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Wang. A scholar is included among the top collaborators of Haibo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Wang. Haibo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Tiantian, Sen Han, Deming Zhao, et al.. (2025). Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research. European Journal Of Haematology. 115(4). 322–333.

Zang, Jian, et al.. (2025). Emerging Nanozyme Strategies for Precision Breast Cancer Treatment. Advanced Science. 12(46). e14085–e14085.

Geng, Cuizhi, Quchang Ouyang, Haibo Wang, et al.. (2024). Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.. Journal of Clinical Oncology. 42(16_suppl). 1054–1054. 1 indexed citations

Jiang, Xiaomin, et al.. (2023). Triptonodiol, a Diterpenoid Extracted from Tripterygium wilfordii, Inhibits the Migration and Invasion of Non-Small-Cell Lung Cancer. Molecules. 28(12). 4708–4708. 6 indexed citations

Ma, Tianyi, Meng Lv, Zhi‐Dong Lv, et al.. (2023). Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study. Frontiers in Oncology. 13. 1130734–1130734. 5 indexed citations

Zhang, Xia, et al.. (2023). Synthesis of an efficient VPO catalyst for the selective oxidation of n-butane to the MA product: Mechanism of crystal transformation. Chemical Engineering Science. 274. 118708–118708. 5 indexed citations

Shen, Jiacheng, Miao Zhu, Yuanyuan Luo, et al.. (2023). Anti-Inflammatory and Analgesic Effects of Chinese Medicine TongFengKang in the Treatment of Gouty Arthritis. International Journal of Pharmacology. 19(5). 604–615. 1 indexed citations

Zhang, Jing, et al.. (2023). Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.. SHILAP Revista de lepidopterología. 20(4). 466–472. 3 indexed citations

Wang, Tao, Colin P. Derdeyn, Osama O. Zaidat, et al.. (2023). Stenting versus medical therapy alone for symptomatic intracranial arterial stenosis: protocol for a systematic review and individual patient data meta-analysis. BMJ Open. 13(6). e071668–e071668. 2 indexed citations

10.

Chen, Cong, Fang Li, Haibo Wang, et al.. (2023). Preparation of UFM1‐Derived Probes through Highly Optimized Total Chemical Synthesis**. Chemistry - A European Journal. 29(37). e202300414–e202300414. 4 indexed citations

11.

Li, Yiqun, Zhongsheng Tong, Quchang Ouyang, et al.. (2023). Real‐world treatment patterns and outcomes of pyrotinib‐based therapy in patients with HER2‐positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study. International Journal of Cancer. 153(10). 1809–1818. 5 indexed citations

12.

Zhang, She, Qingqing Shi, Xing Sun, et al.. (2022). Swollen inguinal lymph nodes with low fever and night sweat: diagnosis and treatment of case of cat-scratch disease lymphadenitis with sinus formation. Heliyon. 8(9). e10448–e10448. 1 indexed citations

13.

Long, Yang, Siyuan Tan, Qiang Han, et al.. (2020). Efficient water-mediated synthesis of bismuth oxyiodide with several distinct morphologies. CrystEngComm. 22(10). 1754–1761. 4 indexed citations

14.

Yang, Fan, Xiang Huang, Chunxiao Sun, et al.. (2020). Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population. BMC Cancer. 20(1). 255–255. 9 indexed citations

15.

Lv, Meng, Yan Mao, Yuhua Song, et al.. (2020). Clinical Features and Survival of Single Hormone Receptor–Positive Breast Cancer: A Population-Based Study of 531,605 Patients. Clinical Breast Cancer. 20(5). e589–e599. 16 indexed citations

16.

Wang, Haibo. (2016). Research on effect of Celastrus orbiculatus extract on inhibiting invasion and metastasis of human gastric cancer SGC-7901 cells by mediating matrix metalloproteinases group and their inhibitors. Zhongcaoyao. 1345–1350. 1 indexed citations

17.

Yue, Lu, Jinyu Xiang, Ping Sun, et al.. (2016). Relationship Between HSP70 and ERBB2 Expression in Breast Cancer Cell Lines Regarding Drug Resistance.. PubMed. 36(3). 1243–9. 8 indexed citations

18.

Wang, Haibo, Hui Zhao, Xibo Zhang, et al.. (2015). CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells. Molecular Medicine Reports. 12(3). 3902–3908. 15 indexed citations

19.

Shi, Xinyan, et al.. (2012). Clinical features of differentiated thyroid carcinoma diagnosed during pregnancy. Zhonghua putong waike zazhi. 27(8). 635–638. 1 indexed citations

20.

Razzaq, Abdul, Zhiying Ma, & Haibo Wang. (2004). Genetic Transformation of Wheat (Triticum aestivum L): A Review. 2(4). 457–464. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact